Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anxinbao in luteal-phase GnRH-a long protocol for IVF/ICSI
ChiCTR2200063162Phase 4Not yet recruiting
- Sponsor
- Guangdong Women and Children Hospital
- Start
- May 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Anxinbao and follitropin in infertility, sponsored by Guangdong Women and Children Hospital. Primary endpoint: Ongoing pregnancy rate after the first embryo transfer. Planned start May 2022; status: not yet recruiting.
02
Drugs
Anxinbaofollitropin
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2200063162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063162.